Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 54

1.

Dysregulation of serum gamma interferon levels in vascular chronic Q Fever patients provides insights into disease pathogenesis.

Pennings JL, Kremers MN, Hodemaekers HM, Hagenaars JC, Koning OH, Renders NH, Hermans MH, de Klerk A, Notermans DW, Wever PC, Janssen R.

Clin Vaccine Immunol. 2015 Jun;22(6):664-71. doi: 10.1128/CVI.00078-15. Epub 2015 Apr 29.

2.

Single nucleotide polymorphisms in immune response genes in acute Q fever cases with differences in self-reported symptoms.

Wielders CC, Hackert VH, Schimmer B, Hodemaekers HM, de Klerk A, Hoebe CJ, Schneeberger PM, van Duynhoven YT, Janssen R.

Eur J Clin Microbiol Infect Dis. 2015 May;34(5):943-50. doi: 10.1007/s10096-014-2310-9. Epub 2015 Jan 11.

PMID:
25577174
3.

Distinct gene expression responses of two anticonvulsant drugs in a novel human embryonic stem cell based neural differentiation assay protocol.

Schulpen SH, de Jong E, de la Fonteyne LJ, de Klerk A, Piersma AH.

Toxicol In Vitro. 2015 Apr;29(3):449-57. doi: 10.1016/j.tiv.2014.12.001. Epub 2014 Dec 15.

PMID:
25524013
4.

Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials.

Doedée AM, Boland GJ, Pennings JL, de Klerk A, Berbers GA, van der Klis FR, de Melker HE, van Loveren H, Janssen R.

PLoS One. 2014 Jun 4;9(6):e98175. doi: 10.1371/journal.pone.0098175. eCollection 2014.

5.

Correlations between peripheral blood Coxiella burnetii DNA load, interleukin-6 levels, and C-reactive protein levels in patients with acute Q fever.

Kremers MN, Janssen R, Wielders CC, Kampschreur LM, Schneeberger PM, Netten PM, de Klerk A, Hodemaekers HM, Hermans MH, Notermans DW, Wever PC.

Clin Vaccine Immunol. 2014 Apr;21(4):484-7. doi: 10.1128/CVI.00715-13. Epub 2014 Jan 29.

6.

Effect of flow rate and humidifier. What are the limits of these interactions?

Esquinas AM, de Klerk A.

Resuscitation. 2013 Dec;84(12):e155. doi: 10.1016/j.resuscitation.2013.06.028. Epub 2013 Aug 15. No abstract available.

PMID:
23954663
7.

An ecotoxicological screening tool to prioritise acid mine drainage impacted streams for future restoration.

Oberholster PJ, Genthe B, Hobbs P, Cheng PH, de Klerk AR, Botha AM.

Environ Pollut. 2013 May;176:244-53. doi: 10.1016/j.envpol.2013.01.010. Epub 2013 Feb 26.

PMID:
23434775
8.

Heat and Moisture Exchangers and Humidification Efficacy in Pediatrics: Effects of Ventilator Settings and ETT Leakage.

de Klerk A, Esquinas AM.

Crit Care Res Pract. 2012;2012:585280. doi: 10.1155/2012/585280. Epub 2012 Aug 1. No abstract available.

9.

[Time to address the physician crisis on a qualitative level].

De Klerk A.

Lakartidningen. 2012 May 30-Jun 4;109(22):1072-3. Swedish. No abstract available.

PMID:
22808655
10.

Basal insulin and cardiovascular and other outcomes in dysglycemia.

ORIGIN Trial Investigators, Gerstein HC, Bosch J, Dagenais GR, Díaz R, Jung H, Maggioni AP, Pogue J, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):319-28. doi: 10.1056/NEJMoa1203858. Epub 2012 Jun 11.

11.

n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia.

ORIGIN Trial Investigators, Bosch J, Gerstein HC, Dagenais GR, Díaz R, Dyal L, Jung H, Maggiono AP, Probstfield J, Ramachandran A, Riddle MC, Rydén LE, Yusuf S.

N Engl J Med. 2012 Jul 26;367(4):309-18. doi: 10.1056/NEJMoa1203859. Epub 2012 Jun 11.

12.

A quantitative approach to assess the potency of skin sensitizers in the elicitation phase.

Ezendam J, Vermeulen JP, de Klerk A, de Jong WH, van Loveren H.

Toxicology. 2012 Sep 4;299(1):20-4. doi: 10.1016/j.tox.2012.05.002. Epub 2012 May 4.

PMID:
22564262
13.

Clinical review: humidifiers during non-invasive ventilation--key topics and practical implications.

Esquinas Rodriguez AM, Scala R, Soroksky A, BaHammam A, de Klerk A, Valipour A, Chiumello D, Martin C, Holland AE.

Crit Care. 2012 Feb 8;16(1):203. doi: 10.1186/cc10534. Review.

14.

Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity.

Schuurhof A, Bont L, Hodemaekers HM, de Klerk A, de Groot H, Hofland RW, van de Pol AC, Kimpen JL, Janssen R.

Eur Respir J. 2012 Jun;39(6):1475-81. doi: 10.1183/09031936.00012311. Epub 2012 Jan 20.

15.

Randomized trial comparing 3 approaches to the initial respiratory management of preterm neonates.

Dunn MS, Kaempf J, de Klerk A, de Klerk R, Reilly M, Howard D, Ferrelli K, O'Conor J, Soll RF; Vermont Oxford Network DRM Study Group.

Pediatrics. 2011 Nov;128(5):e1069-76. doi: 10.1542/peds.2010-3848. Epub 2011 Oct 24.

PMID:
22025591
16.

Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associated with post-bronchiolitis wheeze.

Schuurhof A, Janssen R, de Groot H, Hodemaekers HM, de Klerk A, Kimpen JL, Bont L.

Respir Res. 2011 Sep 12;12:121. doi: 10.1186/1465-9921-12-121.

17.

Contact and respiratory sensitizers can be identified by cytokine profiles following inhalation exposure.

De Jong WH, Arts JH, De Klerk A, Schijf MA, Ezendam J, Kuper CF, Van Loveren H.

Toxicology. 2009 Jul 10;261(3):103-11. doi: 10.1016/j.tox.2009.04.057. Epub 2009 May 5.

PMID:
19422874
18.

Effects of Bifidobacterium animalis administered during lactation on allergic and autoimmune responses in rodents.

Ezendam J, de Klerk A, Gremmer ER, van Loveren H.

Clin Exp Immunol. 2008 Dec;154(3):424-31. doi: 10.1111/j.1365-2249.2008.03788.x.

19.

Effect of Prolonged Repeated Exposure to Formaldehyde Donors with Doses Below the EC3 Value on Draining Lymph Node Responses.

De Jong WH, De Klerk A, Beek MT, Veenman C, Van Loveren H.

J Immunotoxicol. 2007 Jul;4(3):239-46. doi: 10.1080/15476910701507967.

PMID:
18958734
20.

The respiratory local lymph node assay as a tool to study respiratory sensitizers.

Arts JH, de Jong WH, van Triel JJ, Schijf MA, de Klerk A, van Loveren H, Kuper CF.

Toxicol Sci. 2008 Dec;106(2):423-34. doi: 10.1093/toxsci/kfn199. Epub 2008 Sep 23.

PMID:
18815142

Supplemental Content

Loading ...
Support Center